Additionally, although canonical cell proliferation can be regulated by VPS34 through downregulating TSC2 and activating mTORC1 (Fig. 4A), research also showed that VPS34 inhibition decreased micropinocytosis in TSC2-null cells and suppressed TSC2-deficient tumor growth in mice [111]. This evidence concerns the gene TSC2 and neoplasm.